Dow Down0.92% Nasdaq Down0.83%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NCM
1.42 0.05(3.40%)
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (34,598) (43,951) (20,141)
Operating Activities, Cash Flows Provided By or Used In
Depreciation641  431  112  
Adjustments To Net Income3,647  10,140  (4,279)
Changes In Accounts Receivables -   -   -  
Changes In Liabilities(7,602)22,836  1,815  
Changes In Inventories -   -   -  
Changes In Other Operating Activities489  (98)(343)
Total Cash Flow From Operating Activities (37,423) (10,642) (22,836)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures -   -  (15)
Investments32,216  (21,382)4,159  
Other Cash flows from Investing Activities -  11  34  
Total Cash Flows From Investing Activities 32,216   (21,371) 4,178  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock12,570  22,660  4,121  
Net Borrowings(7,182)14,982  9,625  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 5,388   37,642   13,746  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 181   5,629   (4,912)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.